Accolate Class Action Lawsuits

Accolate Class Action Lawsuits Information

Accolate is a non-steroidal tablet intended for the prevention and continuous treatment of asthma in children and adults. FDA approved in September 1996, Accolate is manufactured by Zeneca Pharmaceuticals. In approximately 10 months on the market, Accolate was prescribed to around 250,000 U.S. patients.

On July 22, 1997, the manufacturer of Accolate sent a letter to healthcare professionals that the company was making changes to the enclosed package insert for the asthma drug. Included in the revisions were warnings that the drug had been associated to rare occurrences of eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy sometimes presenting as Churg Strauss Syndrome. The Precautions and Adverse Reactions sections of the revised package insert for Accolate included the changes.

Accolate Side Effects

Accolate manufacturer AstraZeneca warned that Accolate side effects were potentially deadly. Accolate side effects included severe liver damage. First surfacing in the beginning of 2000, Accolate side effects had been more closely monitored by the FDA. The FDA told AstraZeneca to alert physicians of the dangerous Accolate side effects in September 2000. The company did not send out official FDA warnings regarding Accolate side effects, but instead just sent out physician notices in that month’s Physician’s Desk Reference.

Women are at a much higher risk for suffering Accolate side effects like liver damage and it is advised for women to undergo regular blood tests to screen for the presence of Accolate side effects. Accolate patients experiencing fever, stomach pain, rash, jaundice, or nausea may be suffering serious Accolate side effects and should consult their physician immediately.

More Accolate Information

Accolate is an asthma prescription medication that entered the U.S. market in 1996. At the time, Accolate patients did not receive complete Accolate information regarding the safety of the drug. The FDA announced new Accolate information after one year on the market when finding rare occurring side effects, including eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy sometimes presenting as Churg Strauss Syndrome.

When Accolate information surfaced even later, linking the asthma medication to instances of severe liver damage especially in women, an official FDA warning was never issued. Instead, the new Accolate information was given to physicians through the September 2000 publication of Physician's Desk Reference. All patients have a right to receive complete Accolate information while taking the drug, or considering using the drug.

• Dangerous Drugs Lawsuits News

For more free legal information on known dangerous drugs and Class Action Lawsuits, please use the links below:

• Accolate
• Accutane
• Advair
• Androstenedione
• Ativan
• Avandia
• Baycol
• Bextra
• Celebrex
• Cold-Eeze
• Crestor
• Ephedra
• Fen-Phen
• Herceptin
• Lariam
• Lamictal
• Lamisil
• Lotronex
• Meridia
• Naproxen
• Neurontin
• Ortho Evra
• OxyContin
• Palladone
• Paxil
• PPA
• Propulsid
• Protopic
• Redux
• Rezulin
• Risperdal
• Serevent
• Seroquel
• Serzone
• Thimerosal
• Viagra
• Viga
• Vioxx
• Zicam
• Zoloft
• Zyprexa